HLA-G and B-cell chronic lymphocytic leukemia: Similarly, plasma samples from CLL patients were reported to contain increased levels of soluble HLA-G, the ligand of the inhibitory receptor (KIR)2DL4, and to be capable of dampening both the viability and cytotoxic function of NK cells from healthy donors in vitro (45).